Loading live market data…

Addex Therapeutics Ltd

NASDAQ:ADXN

$6.185 USD

$0.39 (6.64%)

Volume
2.56K
Average Volume
3.79K
Market Capitalization
$4.45M
P/E Ratio
-0.76
Dividend Yield
0.00%
Price Target
$30.00
Year High
$12.05
Year Low
$5.41
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$0.97

NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)

0

NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)

0

AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)

-$

ADXN Estimated and Actual Revenue by Quarter

Get MSFT Insider Trade Alerts

ADXN Insider Trading History

Insider Name Title Date Transaction Cost Filing Date
Mills Roger director, officer: CHIEF MEDICAL OFFICER 2026-03-18 0 2026-03-25
Mills Roger director, officer: CHIEF MEDICAL OFFICER 2024-01-08 0.064 2026-03-25
Lawton Vincent Michael director 2026-03-18 0 2026-03-25
Lawton Vincent Michael director 2024-01-08 0.064 2026-03-25
Teyssedou Lenaic Nathanael officer: PRINCIPAL ACCOUNTING OFFICER 2022-10-05 0.166 2026-03-25
Teyssedou Lenaic Nathanael officer: PRINCIPAL ACCOUNTING OFFICER 2023-05-12 0.055 2026-03-25
Teyssedou Lenaic Nathanael officer: PRINCIPAL ACCOUNTING OFFICER 2024-01-08 0.064 2026-03-25
Kalinichev Mikhail officer: HEAD OF TRANSLATIONAL SCIENCE 2026-03-18 0 2026-03-25
Kalinichev Mikhail officer: HEAD OF TRANSLATIONAL SCIENCE 2024-08-01 0.064 2026-03-25
Hill Raymond George director 2026-03-18 0 2026-03-25
Hill Raymond George director 2024-01-08 0.064 2026-03-25
Dyer Timothy Mark director, 10 percent owner, officer: Chief Executive Officer 2026-03-18 0 2026-03-18
Dyer Timothy Mark director, 10 percent owner, officer: Chief Executive Officer 2024-01-08 0.064 2026-03-18
Nunn Jason Raleigh director 2026-03-18 0 2026-03-18
Nunn Jason Raleigh director 2024-01-08 0.064 2026-03-18
Manke Isaac director 2026-03-18 0 2026-03-18
Manke Isaac director 2024-01-08 0.064 2026-03-18